Fundamental Valuation Report Amedisys(AMED:NAS) Healthcare:Medical Care Facilities This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$283.99 (USD) 04/15/2021 Weighted Valuation$228.18 (USD) Overall RatingOvervalued by 19.7% Valuation Models Multiples: $191.51 (USD) Comparables: $177.85 …

Amedisys (AMED:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.01 (USD) 04/15/2021 Weighted Valuation$5.93 (USD) Overall RatingUndervalued by 18.4% Valuation Models Comparables: $5.93 (USD) Valuation Methods …

Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report American Tower(AMT:NYS) Real Estate:REIT – Specialty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$247.16 (USD) 04/15/2021 Weighted Valuation$243.96 (USD) Overall RatingFairly valued to slightly Overvalued by 1.3% …

American Tower (AMT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Aclaris Therapeutics(ACRS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.82 (USD) 04/14/2021 Weighted Valuation$9.19 (USD) Overall RatingOvervalued by 67.0% Valuation Models Comparables: $9.19 (USD) Valuation Methods …

Aclaris Therapeutics (ACRS:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Adaptimmune Therapeutics(ADAP:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.04 (USD) 04/14/2021 Weighted Valuation$5.05 (USD) Overall RatingFairly valued to slightly Undervalued by 0.3% Valuation Models Comparables: $7.73 …

Adaptimmune Therapeutics (ADAP:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report ADT(ADT:NYS) Industrials:Security & Protection Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.32 (USD) 04/14/2021 Weighted Valuation$10.98 (USD) Overall RatingUndervalued by 17.8% Valuation Models Multiples: $9.14 (USD) …

ADT (ADT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report American Electric Power(AEP:NAS) Utilities:Utilities – Regulated Electric This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$87.07 (USD) 04/14/2021 Weighted Valuation$87.29 (USD) Overall RatingFairly valued to slightly Undervalued by …

American Electric Power (AEP:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report AES(AES:NYS) Utilities:Utilities – Diversified This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$28.37 (USD) 04/14/2021 Weighted Valuation$30.33 (USD) Overall RatingUndervalued by 6.9% Valuation Models Comparables: $37.68 (USD) Valuation …

AES (AES:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report American Financial Group(AFG:NYS) Financial Services:Insurance – Property & Casualty This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$119.07 (USD) 04/14/2021 Weighted Valuation$119.73 (USD) Overall RatingFairly valued …

American Financial Group (AFG:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Agios Pharmaceuticals(AGIO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$53.36 (USD) 04/14/2021 Weighted Valuation$58.00 (USD) Overall RatingUndervalued by 8.7% Valuation Models Comparables: $74.03 (USD) Multiples: $64.54 (USD) …

Agios Pharmaceuticals (AGIO:NAS) Fundamental Valuation Report Read more »

Read More